MarketInOut Stock Screener Log In | Sign Up
 

Bristol Myers Squibb Co

NYSE • Healthcare • Drug Manufacturers - General • Quote as of 05/08/2026
Bristol Myers Squibb Co stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeNYSE
Market Capitalization115,214 mln
Float2,039 mln
Earnings Date07/30/2026

EPS

3.57
Solid

P / E

15.73
Moderately valued

Piotroski F-Score

8 / 9
Very strong

Beneish M-Score

-2.6
Likely reliable

1-Year Forecast

63.32
Modest upside

Relative Strength

12 / 100
Significantly lagging

Business Description

Founded in 1887 and based in Princeton, New Jersey, Bristol-Myers Squibb is a global biopharmaceutical company that researches, makes, and sells medicines across a wide range of serious health conditions, including cancer, blood disorders, heart disease, and autoimmune and neurological conditions. Its portfolio includes well-known treatments such as Opdivo, Yervoy, Eliquis, and Revlimid, among many others. The company distributes its products through wholesalers, pharmacies, hospitals, and government agencies around the world.

Key Fundamentals

EPS3.57
P/E15.73
ROE41.25
RPS23.76
ROIC16.62
ROA7.80
Interest Cover7.52
EBITDA, mln14,841
EV / EBITDA10.47
EV / EBIT13.62
Revenue, mln48,483
EV / Revenue3.20

Financial Strength

Altman Z-Score2.29
Piotroski F-Score 8 / 9
Beneish M-Score-2.6
Price to Intrinsic Value0.82
1-Year Target Price63.32
Shiller PE Ratio35.47
Short Ratio2.50
Short % of Float1.59

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -3.54% 13 / 100   
1 Month -5.57% 12 / 100   
2 Months 3.06% 53 / 100   
6 Months 23.54% 82 / 100   
1 Year 23.84% 57 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us